Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value: $273M (100.0% shares, 0.0% debt)

Holdings (19)

REPL Replimune Group 27.1%

Value $74.06M Shares 4,288,154 Est. Cost $17.40 Unrealized +9.6%

— Imago Biosciences 16.6%

Value $45.43M Shares 3,018,737 Est. Cost $20.03 Unrealized —

NUVB Nuvation Bio 12.4%

Value $33.76M Shares 15,072,340 Est. Cost $11.18 Unrealized -74.5%

— Cincor Pharma 6.7%

Value $18.41M Shares 560,985 Est. Cost $17.54 Unrealized —

GOSS Gossamer Bio 6.6%

Value $17.97M Shares 1,500,000 Est. Cost $20.85 Unrealized -40.5%

— Morphic Holding 6.2%

Value $16.92M Shares 597,723 Est. Cost $19.82 Unrealized —

— Alpine Immune Sciences 5.4%

Value $14.61M Shares 2,029,580 Est. Cost $9.48 Unrealized —

— Kronos Bio 4.7%

Value $12.79M Shares 3,818,283 Est. Cost $29.87 Unrealized —

— Ikena Oncology 2.9%

Value $7.984M Shares 2,249,123 Est. Cost $28.25 Unrealized —

IMUX Immunic Inc 2.1%

Value $5.651M Shares 1,788,160 Est. Cost $13.89 Unrealized -69.9%

— Paratek Pharmaceuticals 1.9%

Value $5.066M Shares 1,971,241 Est. Cost $34.18 Unrealized —

SANA Sana Biotechnology, Inc. 1.9%

Value $5.063M Shares 843,750 Est. Cost $32.56 Unrealized -77.8%

— Omega Alpha SPAC 1.8%

Value $4.975M Shares 501,000 Est. Cost $9.98 Unrealized —

— Theseus Pharmaceuticals 1.5%

Value $4.127M Shares 711,479 Est. Cost $12.68 Unrealized —

— Spruce Biosciences 1.1%

Value $2.961M Shares 2,161,022 Est. Cost $24.31 Unrealized —

SYRS Syros Pharmaceuticals 0.6%

Value $1.618M Shares 251,270 Est. Cost $8.12 Unrealized 0.0%

— Jounce Therapeutics 0.2%

Value $645K Shares 275,513 Est. Cost $21.99 Unrealized —

— ESSA Pharma 0.2%

Value $597K Shares 328,196 Est. Cost $3.14 Unrealized —

— Senti Biosciences, Inc. 0.2%

Value $425K Shares 195,792 Est. Cost $1.97 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
REPL	Replimune Group	4,288,154	$74.06M	27.1%	$17.40	+9.6%	Common Stock	76029N106
—	Imago Biosciences	3,018,737	$45.43M	16.6%	$20.03	—	Common Stock	45250K107
NUVB	Nuvation Bio	15,072,340	$33.76M	12.4%	$11.18	-74.5%	Common Stock Class A	67080N101
—	Cincor Pharma	560,985	$18.41M	6.7%	$17.54	—	Common Stock	17240Y109
GOSS	Gossamer Bio	1,500,000	$17.97M	6.6%	$20.85	-40.5%	Common Stock	38341P102
—	Morphic Holding	597,723	$16.92M	6.2%	$19.82	—	Common Stock	61775R105
—	Alpine Immune Sciences	2,029,580	$14.61M	5.4%	$9.48	—	Common Stock	02083G100
—	Kronos Bio	3,818,283	$12.79M	4.7%	$29.87	—	Common Stock	50107A104
—	Ikena Oncology	2,249,123	$7.984M	2.9%	$28.25	—	Common Stock	45175G108
IMUX	Immunic Inc	1,788,160	$5.651M	2.1%	$13.89	-69.9%	Common Stock	4525EP101
—	Paratek Pharmaceuticals	1,971,241	$5.066M	1.9%	$34.18	—	Common Stock	699374302
SANA	Sana Biotechnology, Inc.	843,750	$5.063M	1.9%	$32.56	-77.8%	Common Stock	799566104
—	Omega Alpha SPAC	501,000	$4.975M	1.8%	$9.98	—	Common Stock Class A	G6749V107
—	Theseus Pharmaceuticals	711,479	$4.127M	1.5%	$12.68	—	Common Stock	88369M101
—	Spruce Biosciences	2,161,022	$2.961M	1.1%	$24.31	—	Common Stock	85209E109
SYRS	Syros Pharmaceuticals	251,270	$1.618M	0.6%	$8.12	0.0%	Common Stock	87184Q206
—	Jounce Therapeutics	275,513	$645K	0.2%	$21.99	—	Common Stock	481116101
—	ESSA Pharma	328,196	$597K	0.2%	$3.14	—	Common Stock	29668H708
—	Senti Biosciences, Inc.	195,792	$425K	0.2%	$1.97	—	Common Stock	81726A100